Concepedia

Farideh Miraki‐Moud

FM

Statistics

Publications

26

Citations

2K

H-Index

22

Active since

1999

Affiliations

Queen Mary University of London(Current)

St Bartholomew's Hospital

William Harvey Research Institute

Royal Marsden Hospital

Cancer Research UK

Farideh Miraki‐Moud is an author at Queen Mary University of London specializing in medicine, oncology, and molecular oncology.

Publications per year

1999–2025

26

Publications

26

Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

David Taussig, Farideh Miraki‐Moud, Fernando Anjos‐Afonso et al. · Blood · 2008 · 365 citations

, , +7

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction

David Taussig, Jacques Vargaftig, Farideh Miraki‐Moud et al. · Blood · 2010 · 359 citations · Full text

, , +13

Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation

Farideh Miraki‐Moud, Fernando Anjos‐Afonso, Katharine Hodby et al. · Proceedings of the National Academy of Sciences · 2013 · 153 citations · Full text

, , +17

Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo

Farideh Miraki‐Moud, Essam Ghazaly, Linda Ariza‐McNaughton et al. · Blood · 2015 · 138 citations · Full text

, , +10

Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia

Alexander Waclawiczek, Ashley Hamilton, Kevin Rouault‐Pierre et al. · Journal of Clinical Investigation · 2020 · 104 citations · Full text

, , +17

1–5 of 26